Search for other papers by Lian Hollander-Cohen in
Google Scholar
PubMed
Search for other papers by Benjamin Böhm in
Google Scholar
PubMed
Search for other papers by Krist Hausken in
Google Scholar
PubMed
Search for other papers by Berta Levavi-Sivan in
Google Scholar
PubMed
brain culminate in a signal to the pituitary gland to release the gonadotropins (GTHs). The pituitary GTHs include follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and together are responsible for gametogenesis, steroidogenesis, protein
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Marie Lindhardt Ljubicic in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Margit Bistrup Fischer in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Emmie N Upners in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Alexander S Busch in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Katharina M Main in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anna-Maria Andersson in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Casper P Hagen in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
–pituitary–gonadal axis not available later in life ( 2 ). While the gonadotropins separately have been widely described in most DSD diagnoses (such as 11 , 12 , 13 , 18 , 19 )), the conundrum remains of how the same cells produce the two gonadotropins with a varying
Search for other papers by Tristan Avril in
Google Scholar
PubMed
Search for other papers by Quentin Hennocq in
Google Scholar
PubMed
Search for other papers by Anne-Sophie Lambert in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Search for other papers by Juliane Leger in
Google Scholar
PubMed
Search for other papers by Dominique Simon in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Search for other papers by Laetitia Martinerie in
Google Scholar
PubMed
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Paris-Saclay University, Paris, France
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
cryptorchidism ( 1 ). It can be isolated or part of a combined pituitary hormone deficiency (CPHD) ( 2 ) and is usually in relation to a dysfunction in gonadotropin-releasing hormone (GnRH) secretion or action. The major clinical consequences of CHH are pubertal
Department of Pediatrics, Navarra Hospital Complex, Pamplona, Spain
Navarra Institute for Health Research (IdisNA), Pamplona, Spain
Search for other papers by Teodoro Durá-Travé in
Google Scholar
PubMed
Search for other papers by Fidel Gallinas-Victoriano in
Google Scholar
PubMed
Search for other papers by María Malumbres-Chacon in
Google Scholar
PubMed
Search for other papers by Lotfi Ahmed-Mohamed in
Google Scholar
PubMed
Navarra Institute for Health Research (IdisNA), Pamplona, Spain
Search for other papers by María Jesús Chueca -Guindulain in
Google Scholar
PubMed
Navarra Institute for Health Research (IdisNA), Pamplona, Spain
Search for other papers by Sara Berrade-Zubiri in
Google Scholar
PubMed
a possibility of progression to true precocious puberty; therefore, it would be mandatory to discriminate between the puberty (precocious puberty) and prepubertal (premature thelarche) values of gonadotropins ( 6 ). Laboratory measurement of
Search for other papers by Monica F Stecchini in
Google Scholar
PubMed
Search for other papers by Zilda Braid in
Google Scholar
PubMed
Search for other papers by Candy B More in
Google Scholar
PubMed
Search for other papers by Davi C Aragon in
Google Scholar
PubMed
Search for other papers by Margaret Castro in
Google Scholar
PubMed
Search for other papers by Ayrton C Moreira in
Google Scholar
PubMed
Search for other papers by Sonir R Antonini in
Google Scholar
PubMed
Introduction Gonadotropin-dependent precocious puberty or central precocious puberty (CPP) is caused by reactivation of the hypothalamic-pituitary-gonadal axis (HPG), while gonadotropin-independent precocious puberty or peripheral precocious
Search for other papers by Eleftherios E Deiktakis in
Google Scholar
PubMed
Search for other papers by Eleftheria Ieronymaki in
Google Scholar
PubMed
Search for other papers by Peter Zarén in
Google Scholar
PubMed
Search for other papers by Agnes Hagsund in
Google Scholar
PubMed
Search for other papers by Elin Wirestrand in
Google Scholar
PubMed
Search for other papers by Johan Malm in
Google Scholar
PubMed
Search for other papers by Christos Tsatsanis in
Google Scholar
PubMed
Imperial College London, Institute of Reproductive and Developmental Biology, London, UK
Search for other papers by Ilpo T Huhtaniemi in
Google Scholar
PubMed
Malmö University Hospital, Reproductive Medicine Center, Malmö, Sweden
Search for other papers by Aleksander Giwercman in
Google Scholar
PubMed
Search for other papers by Yvonne Lundberg Giwercman in
Google Scholar
PubMed
Introduction For decades, gonadotropin-releasing hormone (GnRH) agonists have formed the mainstay hormonal treatment of prostate cancer ( 1 ). While they generate suppression of testosterone due to persistent suppression of luteinizing hormone
Search for other papers by Chan Sub Park in
Google Scholar
PubMed
Search for other papers by Jihye Choi in
Google Scholar
PubMed
Search for other papers by Min-Ki Seong in
Google Scholar
PubMed
Search for other papers by Sung-Eun Hong in
Google Scholar
PubMed
Search for other papers by Jae-Sung Kim in
Google Scholar
PubMed
Search for other papers by In-Chul Park in
Google Scholar
PubMed
Search for other papers by Hyesil Seol in
Google Scholar
PubMed
Search for other papers by Woo Chul Noh in
Google Scholar
PubMed
Search for other papers by Hyun-Ah Kim in
Google Scholar
PubMed
in patients with pS6K1-positive than -negative tumors. Estrogen depletion therapy was developed for treating HR-positive breast cancer in recent decades. Gonadotropin-releasing hormone (GnRH) agonists are specific estradiol depletion therapy for
Search for other papers by Rui-yi Tang in
Google Scholar
PubMed
Search for other papers by Rong Chen in
Google Scholar
PubMed
Search for other papers by Miao Ma in
Google Scholar
PubMed
Search for other papers by Shou-qing Lin in
Google Scholar
PubMed
Search for other papers by Yi-wen Zhang in
Google Scholar
PubMed
Search for other papers by Ya-ping Wang in
Google Scholar
PubMed
characteristics and menarche) after the age of 16 years, low oestradiol (E 2 ) concentrations and low or inappropriately normal serum gonadotropin concentrations ( 9 ). All patients had normal results for other pituitary hormones, prolactin, thyroid
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
Introduction The gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are released from the gonadotropic cells in the anterior pituitary gland. In men, the main target cells for LH are Leydig cells with subsequent
Search for other papers by Luminita Nicoleta Cima in
Google Scholar
PubMed
Hematology Department, Fundeni Hospital, Bucharest, Romania
Search for other papers by Anca Colita in
Google Scholar
PubMed
Endocrine Department, Elias Hospital, Bucharest, Romania
Search for other papers by Simona Fica in
Google Scholar
PubMed
review from reliable electronic databases conducted between October 2016 and April 2017 using the following key words related to the topic: ‘gonadotropin-releasing hormone analogues’, ‘GnRHa’, ‘luteinizing hormone-releasing hormone agonist’, ‘LHRHa